Literature DB >> 25686509

Prediction of heart failure in patients with type 2 diabetes mellitus- a systematic review and meta-analysis.

Ying Wang1, Tomoko Negishi1, Kazuaki Negishi1, Thomas H Marwick2.   

Abstract

BACKGROUND: Heart failure (HF) is a major cause of mortality and disability in type 2 diabetes mellitus (T2DM). This study sought to improve the assessment of HF risk in patients with T2DM-a step that would be critical for effective HF screening.
METHODS: A systematic literature search was performed on electronic databases including MEDLINE and EMBASE, using MeSH terms 'heart failure', 'risk factor', 'T2DM', 'cardiac dysfunction', 'stage B heart failure', 'incident heart failure', 'risk assessment', 'risk impact', 'risk score', 'predictor', 'prediction' and related free text terms. The search was limited to human studies in full-length publications in English language journal from 1946 to 2014. Univariable and multivariable relative risk (RR) and hazard ratio (HR) were obtained from each study.
RESULTS: Twenty-one studies (n=1111,569, including 507,637 subjects with T2DM) were included in this analysis with a follow-up ranging from 1 to 12 years. Associations between incident HF and risk variables described in ≥3 studies were reported. This association was greatest for insulin use (HR 2.48; 1.24-4.99), HbA1c 7.0-8.0% (2.41; 1.62-3.59), 5 years increase in age (1.47; 1.25-1.73), fasting glucose (1.28; 1.10-1.51 per standard deviation) and HbA1c (1.18; 1.14-1.23 each 1% increase). After adjustment for confounders, there were strong associations with coronary artery disease (1.77; 1.31, 2.39), HbA1c ≥ 10% (1.66; 1.45-1.89), insulin use (1.43; 1.14-1.79), HbA1c 9.0-10.0% (1.31; 1.14-1.50), fasting glucose (1.27; 1.10-1.47 per standard deviation) and 5 years increase in age (1.26; 1.13-1.40).
CONCLUSION: Among patients with T2DM, five common clinical variables are associated with significantly increased risk of incident HF.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Heart failure; Predictor; Risk factors; Type 2 diabetes mellitus

Mesh:

Year:  2015        PMID: 25686509     DOI: 10.1016/j.diabres.2015.01.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

Review 1.  Echocardiographic feature of diabetic cardiomyopathy: where are we now?

Authors:  Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

2.  Heart Failure in Patients with Diabetes Mellitus.

Authors:  Giuseppe Mc Rosano; Cristiana Vitale; Petar Seferovic
Journal:  Card Fail Rev       Date:  2017-04

Review 3.  Consensus document: management of heart failure in type 2 diabetes mellitus.

Authors:  Upendra Kaul; Saumitra Ray; D Prabhakar; Arun Kochar; Kamal Sharma; Prakash Kumar Hazra; Subhash Chandra; Dharmesh Ramakant Bhai Solanki; Anjan Lal Dutta; Viveka Kumar; M Srinivas Rao; Abraham Oomman; Sameer Dani; Brian Pinto; T R Raghu
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

Review 4.  My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.

Authors:  Manoja K Brahma; Mark E Pepin; Adam R Wende
Journal:  Diabetes Metab J       Date:  2017-02       Impact factor: 5.376

5.  Oxidative Stress and Obesity- and Type 2 Diabetes-Induced Heart Failure.

Authors:  Luc Demaison
Journal:  Antioxidants (Basel)       Date:  2020-07-23

6.  Type 2 diabetes and heart failure: insights from the global DISCOVER study.

Authors:  Suzanne V Arnold; Kamlesh Khunti; Fabrice Bonnet; Bernard Charbonnel; Hungta Chen; Javier Cid-Ruzafa; Andrew Cooper; Peter Fenici; Marilia B Gomes; Niklas Hammar; Linong Ji; Gabriela Luporini-Saraiva; Jesús Medina; Antonio Nicolucci; Larisa Ramirez; Marina V Shestakova; Iichiro Shimomura; Filip Surmont; Fengming Tang; Jiten Vora; Hirotaka Watada; Mikhail Kosiborod
Journal:  ESC Heart Fail       Date:  2021-02-11

7.  Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean.

Authors:  Rodrigo M Carrillo-Larco; Manuel Castillo-Cara; Cecilia Anza-Ramirez; Antonio Bernabé-Ortiz
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01

Review 8.  Metformin: Expanding the Scope of Application-Starting Earlier than Yesterday, Canceling Later.

Authors:  Yulia A Kononova; Nikolai P Likhonosov; Alina Yu Babenko
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

9.  Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study.

Authors:  Justin B Echouffo-Tcheugui; Sui Zhang; Roberta Florido; Carine Hamo; James S Pankow; Erin D Michos; Ronald B Goldberg; Vijay Nambi; Gary Gerstenblith; Wendy S Post; Roger S Blumenthal; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin; Chiadi E Ndumele
Journal:  JACC Heart Fail       Date:  2021-08       Impact factor: 12.544

10.  Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.

Authors:  Mohammed Al-Jarallah; Rajesh Rajan; Ibrahim Al-Zakwani; Raja Dashti; Bassam Bulbanat; Mustafa Ridha; Kadhim Sulaiman; Alawi A Alsheikh-Ali; Prashanth Panduranga; Khalid F AlHabib; Jassim Al Suwaidi; Wael Al-Mahmeed; Hussam AlFaleh; Abdelfatah Elasfar; Ahmed Al-Motarreb; Nooshin Bazargani; Nidal Asaad; Haitham Amin
Journal:  ESC Heart Fail       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.